Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Respiratory Medicine|November 6, 2004
A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challengeWilliam Storms, Paul Chervinsky, Asma F Ghannam, et al.The Journal of Allergy and Clinical Immunology|March 14, 2007
Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trialCynthia Rand, Andrew Bilderback, Kathleen Schiller, et al.Headache|May 31, 2006
Efficacy of Rizatriptan 10 mg administered early in a migraine attackRoger Cady, Vincent Martin, Alexander Mauskop, et al.Headache|April 22, 2008
Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraineRobert Nett, Lisa K Mannix, Loretta Mueller, et al.Journal of Clinical Pharmacology|January 25, 2006
Pharmacokinetic profile of rizatriptan 10-mg tablet and 10-mg orally disintegrating tablet administered with or without water in healthy subjects: an open-label, randomized, single-dose, 3-period crossover studySuzanne K Swan, Harry Alcorn, Anthony Rodgers, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 9, 2004
Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter studyJonathan Ilowite, Robert Webb, Bruce Friedman, et al.Journal of Glaucoma|April 21, 2004
Dorzolamide/Timolol fixed combination versus concomitant administration of brimonidine and timolol in patients with elevated intraocular pressure: a 3-month comparison of efficacy, tolerability, and patient-reported measuresAlfred M Solish, Paul T DeLucca, Deborah A Cassel, et al.The Journal of Allergy and Clinical Immunology|October 10, 2009
Analysis of behavior-related adverse experiences in clinical trials of montelukastGeorge Philip, Carolyn M Hustad, Marie-Pierre Malice, et al.Headache|October 13, 2009
Expanding access to triptans: assessment of clinical outcomeRoger K Cady, Jerome Goldstein, Stephen Silberstein, et al.Headache|December 1, 2007
Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled studyFred Freitag, Frederick R Taylor, Mohammed A Hamid, et al.Pageof 3